Pricing

Pardes Biosciences Inc (PRDS)

followers ·
Sector: FINANCE
Industry: GENERAL FINANCE
CEO: Thomas G. Wiggans
Employees: 30
Web site: pardesbio.com
2173 SALK AVENUE, SUITE 250, PMB#052, CARLSBAD, CA, 92008
415-649-8758

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • FS Development Corp II

Are you looking for this stock instead?

All 13F Filers Prior Change Hedge Funds 1 Prior Change
Pardes Biosciences, Inc. focuses on discovering, developing, and commercializing novel therapeutics. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available